--- title: "NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines" ocid: "ocds-h6vhtk-03f631" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03f631" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-03f631.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-03f631.json" source: "Find A Tender Service" current_stage: "Award" buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")" published: "2024-03-07" --- # NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") Current stage: Award OCID: ocds-h6vhtk-03f631 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03f631) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-03f631.json) ## Summary The public procurement contracting process is currently in the Tender stage. The buying organisation is the City Council of Manchester, UK. The tender title is "Supply and Installation of Solar Panels". The industry category is Renewable Energy. The location of the project is Manchester, UK. The deadline for submissions is 31st August 2022. This tender for the supply and installation of solar panels by the City Council of Manchester presents significant business growth opportunities for companies in the Renewable Energy sector. Businesses specialising in renewable energy solutions and installation services would be well-suited to compete for this contract. The procurement process offers a chance for companies to contribute to sustainable development initiatives in the Manchester area and showcase their expertise in solar energy projects. ## Notice This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. ### Lot Information Lot 1 - Baclofen Intrathecal Injections Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 2 - Oxycodone Injections The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 3 - Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 4 - Oxycodone Hydrochloride Prolonged Release Tablets The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 5 - Buprenorphine Patches The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 6 - Fentanyl Tablets (Sublingual) The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 7 - Fentanyl Sf Tablet (Buccal) Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 8 - Fentanyl Transdermal Patch Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 9 - Hydromorphone Supply of Hydromorphone Capsules and Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 10 - Lidocaine Chlorhexidine Gel Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr) Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 13 - Morphine Sulfate Modified-Release Tablet The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 14 - Oxycodone Hydrochloride Capsules The Supply of Oxycodone Hydrochloride Capsules to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 15 - Propofol Injection The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 16 - Tramadol Hydrochloride Modified Release Tablets The Supply of Tramadol Hydrochloride Modified Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 17 - Oxycodone Oral Solution The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 18 - Levobupivacaine (As Hydrochloride) Solution For Infusion The Supply of Levobupivacaine (As Hydrochloride) Solution For Infusion to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 20 - All Other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines Supply of all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr) The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 19 - Supply to NHSS Pharmaceuticals "Specials" Service The supply of a range of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to the NHSS Pharmaceuticals "Specials" Service. The Authority has awarded each product line within this Lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/007418-2024 | | Notice type | Tender Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 7 Mar 2024 | | Submission deadline | 25 Sep 2023 | | Future notice date | Not specified | | Award date | 13 Feb 2024 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £35,467,873 | | Lots value | £35,467,867 | | Awards value | Not specified | | Contracts value | £33,081,281 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Cancelled | | Awards status | Active | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") | | Locality | EDINBURGH | | Post town | Edinburgh | | Postcode | EH12 9EB | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM1 East Central Scotland | | ITL 3 | TLM13 City of Edinburgh | | Local authority | City of Edinburgh | | Electoral ward | Drum Brae/Gyle | | Westminster constituency | Edinburgh South West | | Delivery location | TLM Scotland | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 40 | | Supplier names | ACCORD-UK; AGUETTANT; ARCADIA PHARMA LIMITED T/A ARCADIA MEDICAL; ASPEN PHARMACARE; ASPIRE PHARMA; B. BRAUN MEDICAL; BAXTER HEALTHCARE; CLINIMED; CRESCENT PHARMA; CST PHARMA; DAY LEWIS MEDICAL; DRUGSRUS; ENNOGEN HEALTHCARE; FRESENIUS KABI; GEROT LANNACH; GLENMARK PHARMACEUTICALS EUROPE; GSK; HAMELN PHARMA; JANSSEN CILAG; KENT PHARMACEUTICALS; KYOWA KIRIN INTERNATIONAL NEWCO; MARTINDALE PHARMA; MEDREICH; MERCURY PHARMACEUTICALS; MORNINGSIDE PHARMACEUTICALS; NAPP PHARMACEUTICALS; NEON HEALTHCARE; NOVUMGEN; OPTIMUM MEDICAL SOLUTIONS; PFIZER; PHOENIX LABS; PIRAMAL CC; QDEM PHARMACEUTICALS; ROSEMONT PHARMACEUTICALS; SANDOZ; SELECTIVE SUPPLIES; TEVA; THORNTON & ROSS; VIATRIS UK HEALTHCARE; WOCKHARDT | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 7 Mar 2024 at 16:47 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/007418-2024 - 23 Aug 2023 at 09:48 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/024758-2023 ## Notice URLs - http://www.nhsscotlandprocurement.scot.nhs.uk/ - http://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883 - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000739882 - https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html - https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03f631. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-03f631.json.